Increased plasma acylation-stimulating protein correlates with hyperlipidemia at late gestation

Jumana Saleh, Katherine Cianflone, Taqdees Chaudhary, Homed Al-Riyami, Abdul Raheem Al-Abri, Riad Bayoumi

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Objectives: Obesity is often associated with negative consequences, including hyperlipidemia and insulin resistance. Weight gain during pregnancy is also associated with major lipid alterations. Fat storage is enhanced in early pregnancy. At late gestation, hyperlipidemia becomes a major manifestation. The acylation-stimulating protein (ASP) is a potent lipogenic adipocytokine that correlates with postprandial triglyceride (TG) clearance in vivo and has been linked to hyperlipidemic disorders. The role of ASP during a normal pregnancy is unknown. The objective of this study was to investigate plasma ASP levels in correlation with the lipid profile during late gestation. Research Methods and Procedures: Seventy healthy women at late gestation and 60 non-pregnant controls of similar age and prepregnancy BMI were included in a cross-sectional study. Fasting plasma ASP levels and the lipid profile of all of the women were measured. Results: ASP levels were markedly elevated in the pregnant women (66%, p <0.001). ASP levels correlated strongly with the elevated levels of TGs (r = 0.608, p <0.000), apolipoprotein B (0.519, p <0.000), and low-density li poprotein-cholesterol (r = 0.405, p <0.000). Multivariate analysis adjusting for BMI and age showed that changes in ASP levels at late gestation were best predicted by TG and apoB levels, accounting for 53.8% of plasma ASP variation. For the controls, ASP strongly correlated with BMI, which was the only significant predictor of ASP levels. Discussion: Gestational hormone alterations during pregnancy may affect ASP function as a lipogenic factor. Increased plasma ASP levels at late gestation and their strong correlation with parameters reflecting very low-density lipoprotein accumulation are suggestive of ASP resistance, which may further contribute to the hyperlipidemic state, shifting energy in the form of TGs to the rapidly growing fetus.

Original languageEnglish
Pages (from-to)646-652
Number of pages7
JournalObesity
Volume15
Issue number3
DOIs
Publication statusPublished - Mar 2007

Fingerprint

Hyperlipidemias
Pregnancy
Apolipoproteins B
Lipids
des-Arg-(77)-complement C3a
Triglycerides
Adipokines
VLDL Lipoproteins
Weight Gain
Insulin Resistance
Pregnant Women
Fasting
Fetus
Multivariate Analysis
Obesity
Cross-Sectional Studies
Fats
Cholesterol
Hormones

Keywords

  • Acylation- stimulating protein
  • Hyperlipidemia
  • Late gestation
  • Pregnancy
  • Very-low-density lipoproteins

ASJC Scopus subject areas

  • Endocrinology
  • Medicine (miscellaneous)
  • Endocrinology, Diabetes and Metabolism
  • Nutrition and Dietetics

Cite this

Saleh, J., Cianflone, K., Chaudhary, T., Al-Riyami, H., Al-Abri, A. R., & Bayoumi, R. (2007). Increased plasma acylation-stimulating protein correlates with hyperlipidemia at late gestation. Obesity, 15(3), 646-652. https://doi.org/10.1038/oby.2007.575

Increased plasma acylation-stimulating protein correlates with hyperlipidemia at late gestation. / Saleh, Jumana; Cianflone, Katherine; Chaudhary, Taqdees; Al-Riyami, Homed; Al-Abri, Abdul Raheem; Bayoumi, Riad.

In: Obesity, Vol. 15, No. 3, 03.2007, p. 646-652.

Research output: Contribution to journalArticle

Saleh, J, Cianflone, K, Chaudhary, T, Al-Riyami, H, Al-Abri, AR & Bayoumi, R 2007, 'Increased plasma acylation-stimulating protein correlates with hyperlipidemia at late gestation', Obesity, vol. 15, no. 3, pp. 646-652. https://doi.org/10.1038/oby.2007.575
Saleh, Jumana ; Cianflone, Katherine ; Chaudhary, Taqdees ; Al-Riyami, Homed ; Al-Abri, Abdul Raheem ; Bayoumi, Riad. / Increased plasma acylation-stimulating protein correlates with hyperlipidemia at late gestation. In: Obesity. 2007 ; Vol. 15, No. 3. pp. 646-652.
@article{f702326b4d6745ee8d0981facd9b8daa,
title = "Increased plasma acylation-stimulating protein correlates with hyperlipidemia at late gestation",
abstract = "Objectives: Obesity is often associated with negative consequences, including hyperlipidemia and insulin resistance. Weight gain during pregnancy is also associated with major lipid alterations. Fat storage is enhanced in early pregnancy. At late gestation, hyperlipidemia becomes a major manifestation. The acylation-stimulating protein (ASP) is a potent lipogenic adipocytokine that correlates with postprandial triglyceride (TG) clearance in vivo and has been linked to hyperlipidemic disorders. The role of ASP during a normal pregnancy is unknown. The objective of this study was to investigate plasma ASP levels in correlation with the lipid profile during late gestation. Research Methods and Procedures: Seventy healthy women at late gestation and 60 non-pregnant controls of similar age and prepregnancy BMI were included in a cross-sectional study. Fasting plasma ASP levels and the lipid profile of all of the women were measured. Results: ASP levels were markedly elevated in the pregnant women (66{\%}, p <0.001). ASP levels correlated strongly with the elevated levels of TGs (r = 0.608, p <0.000), apolipoprotein B (0.519, p <0.000), and low-density li poprotein-cholesterol (r = 0.405, p <0.000). Multivariate analysis adjusting for BMI and age showed that changes in ASP levels at late gestation were best predicted by TG and apoB levels, accounting for 53.8{\%} of plasma ASP variation. For the controls, ASP strongly correlated with BMI, which was the only significant predictor of ASP levels. Discussion: Gestational hormone alterations during pregnancy may affect ASP function as a lipogenic factor. Increased plasma ASP levels at late gestation and their strong correlation with parameters reflecting very low-density lipoprotein accumulation are suggestive of ASP resistance, which may further contribute to the hyperlipidemic state, shifting energy in the form of TGs to the rapidly growing fetus.",
keywords = "Acylation- stimulating protein, Hyperlipidemia, Late gestation, Pregnancy, Very-low-density lipoproteins",
author = "Jumana Saleh and Katherine Cianflone and Taqdees Chaudhary and Homed Al-Riyami and Al-Abri, {Abdul Raheem} and Riad Bayoumi",
year = "2007",
month = "3",
doi = "10.1038/oby.2007.575",
language = "English",
volume = "15",
pages = "646--652",
journal = "Obesity",
issn = "1930-7381",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Increased plasma acylation-stimulating protein correlates with hyperlipidemia at late gestation

AU - Saleh, Jumana

AU - Cianflone, Katherine

AU - Chaudhary, Taqdees

AU - Al-Riyami, Homed

AU - Al-Abri, Abdul Raheem

AU - Bayoumi, Riad

PY - 2007/3

Y1 - 2007/3

N2 - Objectives: Obesity is often associated with negative consequences, including hyperlipidemia and insulin resistance. Weight gain during pregnancy is also associated with major lipid alterations. Fat storage is enhanced in early pregnancy. At late gestation, hyperlipidemia becomes a major manifestation. The acylation-stimulating protein (ASP) is a potent lipogenic adipocytokine that correlates with postprandial triglyceride (TG) clearance in vivo and has been linked to hyperlipidemic disorders. The role of ASP during a normal pregnancy is unknown. The objective of this study was to investigate plasma ASP levels in correlation with the lipid profile during late gestation. Research Methods and Procedures: Seventy healthy women at late gestation and 60 non-pregnant controls of similar age and prepregnancy BMI were included in a cross-sectional study. Fasting plasma ASP levels and the lipid profile of all of the women were measured. Results: ASP levels were markedly elevated in the pregnant women (66%, p <0.001). ASP levels correlated strongly with the elevated levels of TGs (r = 0.608, p <0.000), apolipoprotein B (0.519, p <0.000), and low-density li poprotein-cholesterol (r = 0.405, p <0.000). Multivariate analysis adjusting for BMI and age showed that changes in ASP levels at late gestation were best predicted by TG and apoB levels, accounting for 53.8% of plasma ASP variation. For the controls, ASP strongly correlated with BMI, which was the only significant predictor of ASP levels. Discussion: Gestational hormone alterations during pregnancy may affect ASP function as a lipogenic factor. Increased plasma ASP levels at late gestation and their strong correlation with parameters reflecting very low-density lipoprotein accumulation are suggestive of ASP resistance, which may further contribute to the hyperlipidemic state, shifting energy in the form of TGs to the rapidly growing fetus.

AB - Objectives: Obesity is often associated with negative consequences, including hyperlipidemia and insulin resistance. Weight gain during pregnancy is also associated with major lipid alterations. Fat storage is enhanced in early pregnancy. At late gestation, hyperlipidemia becomes a major manifestation. The acylation-stimulating protein (ASP) is a potent lipogenic adipocytokine that correlates with postprandial triglyceride (TG) clearance in vivo and has been linked to hyperlipidemic disorders. The role of ASP during a normal pregnancy is unknown. The objective of this study was to investigate plasma ASP levels in correlation with the lipid profile during late gestation. Research Methods and Procedures: Seventy healthy women at late gestation and 60 non-pregnant controls of similar age and prepregnancy BMI were included in a cross-sectional study. Fasting plasma ASP levels and the lipid profile of all of the women were measured. Results: ASP levels were markedly elevated in the pregnant women (66%, p <0.001). ASP levels correlated strongly with the elevated levels of TGs (r = 0.608, p <0.000), apolipoprotein B (0.519, p <0.000), and low-density li poprotein-cholesterol (r = 0.405, p <0.000). Multivariate analysis adjusting for BMI and age showed that changes in ASP levels at late gestation were best predicted by TG and apoB levels, accounting for 53.8% of plasma ASP variation. For the controls, ASP strongly correlated with BMI, which was the only significant predictor of ASP levels. Discussion: Gestational hormone alterations during pregnancy may affect ASP function as a lipogenic factor. Increased plasma ASP levels at late gestation and their strong correlation with parameters reflecting very low-density lipoprotein accumulation are suggestive of ASP resistance, which may further contribute to the hyperlipidemic state, shifting energy in the form of TGs to the rapidly growing fetus.

KW - Acylation- stimulating protein

KW - Hyperlipidemia

KW - Late gestation

KW - Pregnancy

KW - Very-low-density lipoproteins

UR - http://www.scopus.com/inward/record.url?scp=34247372682&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247372682&partnerID=8YFLogxK

U2 - 10.1038/oby.2007.575

DO - 10.1038/oby.2007.575

M3 - Article

C2 - 17372315

AN - SCOPUS:34247372682

VL - 15

SP - 646

EP - 652

JO - Obesity

JF - Obesity

SN - 1930-7381

IS - 3

ER -